Evogene Ltd.
EVGN
Rank in Stocks
#31912
Evogene Ltd. is a computational biology firm specializing in the identification... Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop performance through the development of advanced seed traits, agricultural chemicals, and biological products for crops like corn, soybean, wheat, rice, and cotton. The Human Health division focuses on pioneering microbiome-based treatments for conditions such as immuno-oncology, gastrointestinal ailments, and antibiotic-resistant infections, and also offers medical cannabis products. The Industrial Applications segment is dedicated to developing improved castor bean varieties for various industrial feedstock requirements. Evogene has a global footprint, conducting business in the United States, Israel, Brazil, and other international markets. It maintains significant partnerships, including agricultural collaborations with BASF SE, Corteva, and Bayer, and a medical cannabis development agreement with Cannbit Ltd. through its subsidiary, Canonic Ltd. Established in 1999, Evogene Ltd. is headquartered in Rehovot, Israel.
Share Price
$0.2875
Last synced: 2026-11-09
Market Cap
$2.35M
Change (1 day)
6.09%
Change (1 year)
-76.81%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Evogene Ltd. (EVGN)
Category
Healthcare
EPS for Evogene Ltd. (EVGN)
EPS as of June 2026 TTM: $-0.91
According to Evogene Ltd.'s latest financial reports, its current EPS (TTM) is $-0.91. At the end of 2025 the company had an EPS of $-1.08, an increase over its 2024 EPS of $-2.89.
EPS history for Evogene Ltd. from 2011 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.91 | -15.74% |
| 2025 | $-1.08 | -62.63% |
| 2024 | $-2.89 | -44.74% |
| 2023 | $-5.23 | -19.04% |
| 2022 | $-6.46 | 850.00% |
| 2021 | $-0.68 | 6.25% |
| 2020 | $-0.64 | -8.57% |
| 2019 | $-0.70 | -13.58% |
| 2018 | $-0.81 | 0.00% |
| 2017 | $-0.81 | 5.19% |
| 2016 | $-0.77 | 13.24% |
| 2015 | $-0.68 | 17.24% |
| 2014 | $-0.58 | 28.89% |
| 2013 | $-0.45 | 221.43% |
| 2012 | $-0.14 | -450.00% |
| 2011 | $0.04 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,820.88% |
US
|
|
| $-7.07 | 676.92% |
US
|
|
| $-5.29 | 481.32% |
AU
|
|
| $12.88 | -1,515.40% |
BE
|
|
| $21.56 | -2,469.23% |
NL
|
Questions about Evogene Ltd.'s earnings per share (EPS)
What is Evogene Ltd.'s earnings per share (EPS)?
Evogene Ltd.'s earnings per share (EPS) over the last twelve months is $-0.91, as of Jun 2026.
What was Evogene Ltd.'s earnings per share (EPS) in 2025?
In 2025, Evogene Ltd.'s earnings per share (EPS) was $-1.08, compared with $-2.89 in 2024.
How has Evogene Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Evogene Ltd.'s earnings per share (EPS) was highest in 2020 ($-0.64) and lowest in 2022 ($-6.46).
How does Evogene Ltd.'s earnings per share (EPS) compare with similar companies?
Evogene Ltd.'s earnings per share (EPS) ($-0.91) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.